Results 21 to 30 of about 27,934,643 (129)

Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I. [PDF]

open access: yesJ Inherit Metab Dis, 2010
Acute liver failure may be caused by a variety of disorders including inborn errors of metabolism. In those cases, rapid metabolic investigations and adequate treatment may avoid the need for liver transplantation.
de Groot MJ   +7 more
europepmc   +2 more sources

Genetic Spectrum of Cholestasis in Tunisia and Diagnostic Yield of Next-Generation Sequencing: Case Series of 70 Patients. [PDF]

open access: yesClin Genet
Genetic hepatic cholestasis: NGS diagnostic yield. Over a 10‐year period, NGS (gene panel/WES) established a genetic diagnosis in 70% of 66 families with hepatic cholestasis, with a molecular yield of 62%. ABCB11 was the most mutated gene, and PFIC Type 2 was the leading diagnosis, underscoring the critical role of NGS in guiding genetic counseling and
Abdmouleh A   +12 more
europepmc   +2 more sources

Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G>A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran: A case series [PDF]

open access: yes, 2022
Background: Citrullinemia type 1 is an autosomal recessive disease resulting in ammonia accumulation in the blood, and if uncontrolled may progress to coma or death in the early months after birth.
Zeinali, Sirous   +5 more
core   +1 more source

Prevalence of the most common pathogenic variants in three genes for inborn errors of metabolism associated with sudden unexpected death in infancy: a population-based study in south Brazil [PDF]

open access: yesGenetics and Molecular Biology, 2020
Citrullinemia type 1 (CTLNI), long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD), and mut0 methylmalonic acidemia (mut0 MMA) are inborn errors of metabolism (IEMs) associated with sudden unexpected death in infancy (SUDI).
Dévora N. Randon   +8 more
doaj   +1 more source

gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants [PDF]

open access: yes, 2023
Background: Citrullinemia type 1 (CTLN1) is a rare autosomal recessive disease caused by argininosuccinate synthetase (ASS) deficiency. Manifestations vary from the acute neonatal or “classic” form to a milder, late-onset, or “unconventional” form.
Farra, Chantal G.   +19 more
core   +1 more source

Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency

open access: yesStem Cell Research & Therapy, 2017
Background Argininosuccinate synthase (ASS)1 is a urea cycle enzyme that catalyzes the conversion of citrulline and aspartate to argininosuccinate. Mutations in the ASS1 gene cause citrullinemia type I, a rare autosomal recessive disorder characterized ...
Maria Beatriz Herrera Sanchez   +13 more
doaj   +1 more source

Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes. [PDF]

open access: yesAm J Pathol, 2010
International audienceCitrullinemia type I (CTLN1, OMIM# 215700) is an inherited urea cycle disorder that is caused by an argininosuccinate synthetase (ASS) enzyme deficiency.
Perez CJ   +14 more
europepmc   +2 more sources

Rare Adult-onset Citrullinemia Type 1 in the Postpartum Period: A Case Report [PDF]

open access: yes, 2023
Introduction: Citrullinemia type 1 (CTLN1) is a urea cycle disorder caused by defective argininosuccinate synthetase leading to impaired ammonia elimination.
Saab, Mathew   +5 more
core   +1 more source

Genetic Analysis of Peroxisomal Genes Required for Longevity in a Yeast Model of Citrin Deficiency

open access: yesDiseases, 2020
Citrin is a liver-specific mitochondrial aspartate−glutamate carrier encoded by SLC25A13. Citrin deficiency caused by SLC25A13 mutation results in carbohydrate toxicity, citrullinemia type II, and fatty liver diseases, the mechanisms of some of ...
Chalongchai Chalermwat   +3 more
doaj   +1 more source

AGC2 (Citrin) Deficiency—From Recognition of the Disease till Construction of Therapeutic Procedures

open access: yesBiomolecules, 2020
Can you imagine a disease in which intake of an excess amount of sugars or carbohydrates causes hyperammonemia? It is hard to imagine the intake causing hyperammonemia.
Takeyori Saheki   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy